The global robotics in drug discovery market size was valued at USD 1.75 billion in 2025 and is expected to reach USD 4.45 billion by 2033, at a CAGR of 12.40% during the forecast period
The market growth is largely fueled by the increasing integration of automation, artificial intelligence, and advanced robotics into pharmaceutical research processes, leading to improved efficiency, accuracy, and speed in drug discovery workflows across research laboratories and biotech companies
Furthermore, rising demand for faster drug development cycles, cost-effective screening methods, and high-throughput compound testing is establishing Robotics in Drug Discovery as a critical enabler of modern pharmaceutical innovation. These converging factors are accelerating the uptake of Robotics in Drug Discovery solutions, thereby significantly boosting the industry's growth